Transcranial magnetic stimulation in autism spectrum disorder: Challenges, promise, and roadmap for future research

TMS in ASD Consensus Group

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

Autism Spectrum Disorder (ASD) is a behaviorally defined complex neurodevelopmental syndrome characterized by impairments in social communication, by the presence of restricted and repetitive behaviors, interests and activities, and by abnormalities in sensory reactivity. Transcranial magnetic stimulation (TMS) is a promising, emerging tool for the study and potential treatment of ASD. Recent studies suggest that TMS measures provide rapid and noninvasive pathophysiological ASD biomarkers. Furthermore, repetitive TMS (rTMS) may represent a novel treatment strategy for reducing some of the core and associated ASD symptoms. However, the available literature on the TMS use in ASD is preliminary, composed of studies with methodological limitations. Thus, off-label clinical rTMS use for therapeutic interventions in ASD without an investigational device exemption and outside of an IRB approved research trial is premature pending further, adequately powered and controlled trials. Leaders in this field have gathered annually for a two-day conference (prior to the 2014 and 2015 International Meeting for Autism Research, IMFAR) to share recent progress, promote collaboration across laboratories, and establish consensus on protocols. Here we review the literature in the use of TMS in ASD in the context of the unique challenges required for the study and exploration of treatment strategies in this population. We also suggest future directions for this field of investigations. While its true potential in ASD has yet to be delineated, TMS represents an innovative research tool and a novel, possibly transformative approach to the treatment of neurodevelopmental disorders. Autism Res 2016, 9: 184-203.

Original languageEnglish (US)
Pages (from-to)184-203
Number of pages20
JournalAutism Research
Volume9
Issue number2
DOIs
StatePublished - Feb 1 2016
Externally publishedYes

Fingerprint

Transcranial Magnetic Stimulation
Autistic Disorder
Research
Autism Spectrum Disorder
Research Ethics Committees
Therapeutic Uses
Therapeutics
Consensus
Biomarkers
Communication
Equipment and Supplies

Keywords

  • Autism spectrum disorder
  • Consensus
  • Review
  • Transcranial magnetic stimulation
  • Treatment

ASJC Scopus subject areas

  • Neuroscience(all)
  • Clinical Neurology
  • Genetics(clinical)

Cite this

Transcranial magnetic stimulation in autism spectrum disorder : Challenges, promise, and roadmap for future research. / TMS in ASD Consensus Group.

In: Autism Research, Vol. 9, No. 2, 01.02.2016, p. 184-203.

Research output: Contribution to journalArticle

@article{031f1f4c991c4532b478d95b2f758e1b,
title = "Transcranial magnetic stimulation in autism spectrum disorder: Challenges, promise, and roadmap for future research",
abstract = "Autism Spectrum Disorder (ASD) is a behaviorally defined complex neurodevelopmental syndrome characterized by impairments in social communication, by the presence of restricted and repetitive behaviors, interests and activities, and by abnormalities in sensory reactivity. Transcranial magnetic stimulation (TMS) is a promising, emerging tool for the study and potential treatment of ASD. Recent studies suggest that TMS measures provide rapid and noninvasive pathophysiological ASD biomarkers. Furthermore, repetitive TMS (rTMS) may represent a novel treatment strategy for reducing some of the core and associated ASD symptoms. However, the available literature on the TMS use in ASD is preliminary, composed of studies with methodological limitations. Thus, off-label clinical rTMS use for therapeutic interventions in ASD without an investigational device exemption and outside of an IRB approved research trial is premature pending further, adequately powered and controlled trials. Leaders in this field have gathered annually for a two-day conference (prior to the 2014 and 2015 International Meeting for Autism Research, IMFAR) to share recent progress, promote collaboration across laboratories, and establish consensus on protocols. Here we review the literature in the use of TMS in ASD in the context of the unique challenges required for the study and exploration of treatment strategies in this population. We also suggest future directions for this field of investigations. While its true potential in ASD has yet to be delineated, TMS represents an innovative research tool and a novel, possibly transformative approach to the treatment of neurodevelopmental disorders. Autism Res 2016, 9: 184-203.",
keywords = "Autism spectrum disorder, Consensus, Review, Transcranial magnetic stimulation, Treatment",
author = "{TMS in ASD Consensus Group} and Oberman, {Lindsay M.} and Enticott, {Peter G.} and Casanova, {Manuel F.} and Alexander Rotenberg and Alvaro Pascual-Leone and Mccracken, {James T.} and Stephanie Ameis and David Brock and Mark Demitrack and Paul Croarkin and Geraldine Dawson and Winifred Wu and Donald Gilbert and Eric Hollander and Marco Iacoboni and Kelvin Lim and Stewart Mostofsky and Ernest Pedapati and Susan Swedo and Taylor, {Kim Hollingsworth} and Paul Wang and Christopher Wall",
year = "2016",
month = "2",
day = "1",
doi = "10.1002/aur.1567",
language = "English (US)",
volume = "9",
pages = "184--203",
journal = "Autism Research",
issn = "1939-3806",
publisher = "John Wiley and Sons Inc.",
number = "2",

}

TY - JOUR

T1 - Transcranial magnetic stimulation in autism spectrum disorder

T2 - Challenges, promise, and roadmap for future research

AU - TMS in ASD Consensus Group

AU - Oberman, Lindsay M.

AU - Enticott, Peter G.

AU - Casanova, Manuel F.

AU - Rotenberg, Alexander

AU - Pascual-Leone, Alvaro

AU - Mccracken, James T.

AU - Ameis, Stephanie

AU - Brock, David

AU - Demitrack, Mark

AU - Croarkin, Paul

AU - Dawson, Geraldine

AU - Wu, Winifred

AU - Gilbert, Donald

AU - Hollander, Eric

AU - Iacoboni, Marco

AU - Lim, Kelvin

AU - Mostofsky, Stewart

AU - Pedapati, Ernest

AU - Swedo, Susan

AU - Taylor, Kim Hollingsworth

AU - Wang, Paul

AU - Wall, Christopher

PY - 2016/2/1

Y1 - 2016/2/1

N2 - Autism Spectrum Disorder (ASD) is a behaviorally defined complex neurodevelopmental syndrome characterized by impairments in social communication, by the presence of restricted and repetitive behaviors, interests and activities, and by abnormalities in sensory reactivity. Transcranial magnetic stimulation (TMS) is a promising, emerging tool for the study and potential treatment of ASD. Recent studies suggest that TMS measures provide rapid and noninvasive pathophysiological ASD biomarkers. Furthermore, repetitive TMS (rTMS) may represent a novel treatment strategy for reducing some of the core and associated ASD symptoms. However, the available literature on the TMS use in ASD is preliminary, composed of studies with methodological limitations. Thus, off-label clinical rTMS use for therapeutic interventions in ASD without an investigational device exemption and outside of an IRB approved research trial is premature pending further, adequately powered and controlled trials. Leaders in this field have gathered annually for a two-day conference (prior to the 2014 and 2015 International Meeting for Autism Research, IMFAR) to share recent progress, promote collaboration across laboratories, and establish consensus on protocols. Here we review the literature in the use of TMS in ASD in the context of the unique challenges required for the study and exploration of treatment strategies in this population. We also suggest future directions for this field of investigations. While its true potential in ASD has yet to be delineated, TMS represents an innovative research tool and a novel, possibly transformative approach to the treatment of neurodevelopmental disorders. Autism Res 2016, 9: 184-203.

AB - Autism Spectrum Disorder (ASD) is a behaviorally defined complex neurodevelopmental syndrome characterized by impairments in social communication, by the presence of restricted and repetitive behaviors, interests and activities, and by abnormalities in sensory reactivity. Transcranial magnetic stimulation (TMS) is a promising, emerging tool for the study and potential treatment of ASD. Recent studies suggest that TMS measures provide rapid and noninvasive pathophysiological ASD biomarkers. Furthermore, repetitive TMS (rTMS) may represent a novel treatment strategy for reducing some of the core and associated ASD symptoms. However, the available literature on the TMS use in ASD is preliminary, composed of studies with methodological limitations. Thus, off-label clinical rTMS use for therapeutic interventions in ASD without an investigational device exemption and outside of an IRB approved research trial is premature pending further, adequately powered and controlled trials. Leaders in this field have gathered annually for a two-day conference (prior to the 2014 and 2015 International Meeting for Autism Research, IMFAR) to share recent progress, promote collaboration across laboratories, and establish consensus on protocols. Here we review the literature in the use of TMS in ASD in the context of the unique challenges required for the study and exploration of treatment strategies in this population. We also suggest future directions for this field of investigations. While its true potential in ASD has yet to be delineated, TMS represents an innovative research tool and a novel, possibly transformative approach to the treatment of neurodevelopmental disorders. Autism Res 2016, 9: 184-203.

KW - Autism spectrum disorder

KW - Consensus

KW - Review

KW - Transcranial magnetic stimulation

KW - Treatment

UR - http://www.scopus.com/inward/record.url?scp=84958637622&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84958637622&partnerID=8YFLogxK

U2 - 10.1002/aur.1567

DO - 10.1002/aur.1567

M3 - Article

C2 - 26536383

AN - SCOPUS:84958637622

VL - 9

SP - 184

EP - 203

JO - Autism Research

JF - Autism Research

SN - 1939-3806

IS - 2

ER -